Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
eNq1mFFv2jAQx9/5FFHeSQgto50C1cbaDalVGS3atJfKJEcxc+30bAPdp59D6EYnR10Nfozt/O/su/v55PRs/cCCJaCkgvfCJGqFAfBM5JTf98LJ7UXzJDzrN9IFWZKdZd2oFSXtMMgYkbIXlrPRFAiX0fery09g/gcM+40gFdMFZOrFOq0oi74QOb8iRbkmSJeC5sEDqLnIe2Gh1WY0SKVC40V/JfCnLEgGabwd2Z1d3B3vjqdxKfYfqloCXhJ+bxUF7qSZaUTgakAU3At8qvH3yEmbyjFIoTGDEVHzEYolzSG3mpgRJsHJyGyV3wAuGajSiFU8XmQP0kmcLMh6DI9Du9MfzOxArVWz1Uy6nZOkddTpdk+P206mcOeo7FEwm4izu6Tbbp+2jmLgMSNcaekYmpFARZinoFA5eJlXnuwgPL4a/JzKgpGnaCEL16MiSMw0oKl+fxspd3CLhkfMnNk/+lwzFr/R68mWFp48LmE0EJqrGmhcjF0PYiC4gnV9RN04p9bbXKQgDyf7S3A740d6ymjmSjTDHA1STcbDeqAdkAUfiYQJ+oPBN8pzsZKHh8xuUD15X2w4aRUtME/u2qcn75JOx7mGfpgMqrlfzjWKAmKDHyr3ocqQz8S+PDFJaZd6TslDZeOmyREZYVDT5jQdyWLS8Lkr85bo/oqomrCKfj6/dc2Orxrw6WbzaZWmee9PXN2w64PlJhdrHX97ZlcF7qUB1mgHx1ypQr6P49VqFc2JbEpTLhDN8NBc37lJ/XXfXq7rqn2p2OjJ9Wl16b0tQK6F9tqFvm+Tuv1/2wxbbSjUsEcsKiZ7I+fw/PAw/tuhenN79AIe/sxsukmiqOC+2hw9tSruh38TV36BBhDXsxmteQ2pzcs0rl5i+o00Ll9h+o3fzLPjPQ==
FTCCE9EgnjXcmFn7
Listen
